Literature DB >> 15835262

The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease.

Scott E Counts1, Elliott J Mufson.   

Abstract

Dysfunction of nerve growth factor (NGF) and its high (TrkA) and low (p75NTR) affinity receptors has been suggested to underlie the selective degeneration of the nucleus basalis (NB) cholinergic cortical projection neurons in end stage Alzheimer disease (AD). Whether the NGF system is dysfunctional during the prodromal stages of AD has only recently been evaluated. Surprisingly, the number of choline acetyltransferase-containing neurons remains stable despite a significant reduction in NGF receptor-positive cells in people with mild cognitive impairment (MCI), suggesting a phenotypic NGF receptor downregulation but not a frank loss of NB neurons during prodromal AD. Moreover, there is a loss of cortical TrkA in the face of stable p75NTR and increased proNGF levels, the precursor molecule of mature NGF, in early AD. Depending upon the cellular context these changes may result in increased pro-apoptotic signaling, cell survival, or a defect in retrograde transport mechanisms. Alterations in NGF and its receptors within the cholinotrophic NB system in early AD suggest that NGF-mediated cell signaling is required for the longterm survival of these neurons. Therapeutic neurotrophic intervention might delay or prevent NB neuron degeneration and preserve cholinergic cortical function during prodromal AD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15835262     DOI: 10.1093/jnen/64.4.263

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  85 in total

1.  Age-dependent alterations in nerve growth factor (NGF)-related proteins, sortilin, and learning and memory in rats.

Authors:  Alvin V Terry; Ammar Kutiyanawalla; Anilkumar Pillai
Journal:  Physiol Behav       Date:  2010-11-06

2.  Repeated, intermittent exposures to diisopropylfluorophosphate in rats: protracted effects on cholinergic markers, nerve growth factor-related proteins, and cognitive function.

Authors:  A V Terry; J J Buccafusco; D A Gearhart; W D Beck; M-L Middlemore-Risher; J N Truan; G M Schwarz; M Xu; M G Bartlett; A Kutiyanawala; A Pillai
Journal:  Neuroscience       Date:  2010-12-24       Impact factor: 3.590

Review 3.  Dysregulation of Rab5-mediated endocytic pathways in Alzheimer's disease.

Authors:  Wei Xu; Fang Fang; Jianqing Ding; Chengbiao Wu
Journal:  Traffic       Date:  2018-02-05       Impact factor: 6.215

Review 4.  Single cell gene expression profiling in Alzheimer's disease.

Authors:  Stephen D Ginsberg; Shaoli Che; Scott E Counts; Elliott J Mufson
Journal:  NeuroRx       Date:  2006-07

Review 5.  Aging of the brain, neurotrophin signaling, and Alzheimer's disease: is IGF1-R the common culprit?

Authors:  Luigi Puglielli
Journal:  Neurobiol Aging       Date:  2007-02-20       Impact factor: 4.673

Review 6.  Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.

Authors:  Elliott J Mufson; Scott E Counts; Sylvia E Perez; Stephen D Ginsberg
Journal:  Expert Rev Neurother       Date:  2008-11       Impact factor: 4.618

7.  Diminished trkA receptor signaling reveals cholinergic-attentional vulnerability of aging.

Authors:  Vinay Parikh; William M Howe; Ryan M Welchko; Sean X Naughton; Drew E D'Amore; Daniel H Han; Monika Deo; David L Turner; Martin Sarter
Journal:  Eur J Neurosci       Date:  2012-12-11       Impact factor: 3.386

8.  Preservation of cortical sortilin protein levels in MCI and Alzheimer's disease.

Authors:  Elliott J Mufson; Joanne Wuu; Scott E Counts; Anders Nykjaer
Journal:  Neurosci Lett       Date:  2010-01-18       Impact factor: 3.046

Review 9.  Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.

Authors:  Ravi Rajmohan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

10.  ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice.

Authors:  C Tiveron; L Fasulo; S Capsoni; F Malerba; S Marinelli; F Paoletti; S Piccinin; R Scardigli; G Amato; R Brandi; P Capelli; S D'Aguanno; F Florenzano; F La Regina; A Lecci; A Manca; G Meli; L Pistillo; N Berretta; R Nisticò; F Pavone; A Cattaneo
Journal:  Cell Death Differ       Date:  2013-03-29       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.